Search research articles
Contact Us
Filters
Showing results (31-40 of 102) with videos related to
Page
of 11
Sort By:
Endocrine Connections
|
December 9, 2017
Serum and urine vitamin D metabolite analysis in early preeclampsia
J A Tamblyn, C Jenkinson, D P Larner, et al.
The Journal of Clinical Investigation
|
July 1, 1993
Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3
K Kristjansson, A R Rut, M Hewison, et al.
Endocrinology
|
April 28, 1999
Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium
R Bland, E A Walker, S V Hughes, et al.
Bone
|
February 1, 1996
Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia
P S Rowe, A C Ong, F J Cockerill, et al.
The Journal of Endocrinology
|
February 10, 2015
Immunological role of vitamin D at the maternal-fetal interface
J A Tamblyn, M Hewison, C L Wagner, et al.
Immunology
|
October 1, 1989
Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells
M Hewison, S Barker, A Brennan, et al.
The Journal of Biological Chemistry
|
April 11, 2001
Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1
E A Walker, A M Clark, M Hewison, et al.
Endocrinology
|
July 1, 1997
Differential expression of nuclear 11beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues
M D Petrelli, S S Lim-Tio, J Condon, et al.
Postgraduate Medical Journal
|
September 1, 1990
Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease
R Karmali, S Barker, M Hewison, et al.
British Journal of Haematology
|
May 8, 1999
Clofibric acid: a potential therapeutic agent in AML and MDS
S L Fenton, M T Drayson, M Hewison, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 102) with videos related to
Sort By:
Page
of 11
Endocrine Connections
|
December 9, 2017
Serum and urine vitamin D metabolite analysis in early preeclampsia
J A Tamblyn, C Jenkinson, D P Larner, et al.
The Journal of Clinical Investigation
|
July 1, 1993
Two mutations in the hormone binding domain of the vitamin D receptor cause tissue resistance to 1,25 dihydroxyvitamin D3
K Kristjansson, A R Rut, M Hewison, et al.
Endocrinology
|
April 28, 1999
Constitutive expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in a transformed human proximal tubule cell line: evidence for direct regulation of vitamin D metabolism by calcium
R Bland, E A Walker, S V Hughes, et al.
Bone
|
February 1, 1996
Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia
P S Rowe, A C Ong, F J Cockerill, et al.
The Journal of Endocrinology
|
February 10, 2015
Immunological role of vitamin D at the maternal-fetal interface
J A Tamblyn, M Hewison, C L Wagner, et al.
Immunology
|
October 1, 1989
Autocrine regulation of 1,25-dihydroxycholecalciferol metabolism in myelomonocytic cells
M Hewison, S Barker, A Brennan, et al.
The Journal of Biological Chemistry
|
April 11, 2001
Functional expression, characterization, and purification of the catalytic domain of human 11-beta -hydroxysteroid dehydrogenase type 1
E A Walker, A M Clark, M Hewison, et al.
Endocrinology
|
July 1, 1997
Differential expression of nuclear 11beta-hydroxysteroid dehydrogenase type 2 in mineralocorticoid receptor positive and negative tissues
M D Petrelli, S S Lim-Tio, J Condon, et al.
Postgraduate Medical Journal
|
September 1, 1990
Intermittent hypercalcaemia and vitamin D sensitivity in Hodgkin's disease
R Karmali, S Barker, M Hewison, et al.
British Journal of Haematology
|
May 8, 1999
Clofibric acid: a potential therapeutic agent in AML and MDS
S L Fenton, M T Drayson, M Hewison, et al.
Page
of 11